Rising Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RISING, and what generic and branded alternatives to RISING drugs are available?
RISING has three hundred and three approved drugs.
There are three tentative approvals on RISING drugs.
Drugs and US Patents for Rising
Expired US Patents for Rising
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Rising | SULFAMYLON | mafenide acetate | CREAM;TOPICAL | 016763-001 | Approved Prior to Jan 1, 1982 | 3,497,599 | ⤷ Subscribe |
Rising | SUFENTA PRESERVATIVE FREE | sufentanil citrate | INJECTABLE;INJECTION | 019050-001 | May 4, 1984 | 3,998,834 | ⤷ Subscribe |
Rising | ALFENTA | alfentanil hydrochloride | INJECTABLE;INJECTION | 019353-001 | Dec 29, 1986 | 4,167,574 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.